Skip to main content

Table 2 Serum lipid profile and glucose levels of study population by HAART status at Burayu Health Center, Addis Ababa, Ethiopia, 2012

From: Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study

Parameters

HAART initiated (n=126)

Non-HAART (n=126)

N (%)

N (%)

Glucose

Mean ± SD

97.1 ± 15.7

92.2 ± 16.9*

≤110 mg/dl

116(92.1)

119(94.4)

>110 mg/dl

10(7.9)

7(5.6)

Triglycerides

Mean ± SD

162.2 ± 92.7

131.5 ± 55.3**

<150 mg/dl

67(53.2)

87(69)

≥150 mg/dl

59(46.8)

39(31)*

Total cholesterol

Mean ± SD

194.3 ± 45.2

147.2 ± 37.7***

<200 mg/dl

73(57.9)

112(88.9)

≥200 mg/dl

53(42.1)

14(11.1)***

HDL-cholesterol

Mean ± SD

40.9 ± 12.9

32.6 ± 11.3***

<40 mg/dl

64(50.8)

92(73)***

≥40 mg/dl

62(49.2)

34(27)

LDL-cholesterol

Mean ± SD

107.2 ± 35

81.4 ± 29.3***

<130 mg/dl

97(77)

117(92.9)

≥130 mg/dl

29(23)

9(7.1)***

  1. HAART, highly active antiretroviral therapy; HDL, high-density lipoprotein; LDL, low- density lipoprotein; SD, standard deviation; *p-value =0.01; **p-value =0.002; *** p-value <0.0001.